Literature DB >> 19167971

Usefulness of a 13C-labeled mixed triglyceride breath test for assessing pancreatic exocrine function after pancreatic surgery.

Hiroyuki Nakamura1, Masahiko Morifuji, Yoshiaki Murakami, Kenichiro Uemura, Hiroki Ohge, Yasuo Hayashidani, Takeshi Sudo, Taijiro Sueda.   

Abstract

BACKGROUND: Although the fecal elastase-1 test is a satisfactory pancreatic exocrine function test, breath tests that use stable isotopes have been developed recently as alternatives. We evaluated the usefulness of a (13)C-labeled mixed triglyceride breath test for assessing pancreatic exocrine function after pancreatic surgery.
METHODS: The breath test and the fecal elastase-1 test were performed on 7 healthy volunteers, 10 patients with chronic pancreatitis, and 95 patients after pancreatic surgery. The breath test was analyzed with isotope ratio mass spectrometry and the cumulative recovery of (13)CO(2) at 7 hours (% dose (13)C cum 7h) was calculated. The fecal elastase-1 concentration was determined immunoenzymatically.
RESULTS: Both the fecal elastase-1 concentration and the % dose (13)C cum 7h of chronic pancreatitis patients and pancreatic resection patients were less than those of healthy volunteers. In all subjects, % dose (13)C cum 7h correlated with the fecal elastase-1 concentration (n = 112, R(2) = 0.14, P < .01). Accuracy rates for clinical symptoms, including clinical steatorrhea, for the fecal test and the breath test were 62 and 88%, respectively.
CONCLUSION: The (13)C-labeled mixed triglyceride breath test might be more useful than the fecal elastase-1 test for evaluating pancreatic exocrine function after pancreatic resection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19167971     DOI: 10.1016/j.surg.2008.08.013

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  12 in total

1.  Diagnosing exocrine pancreatic insufficiency after surgery: when and which patients to treat.

Authors:  Helmut Friess; Christoph W Michalski
Journal:  HPB (Oxford)       Date:  2009-12       Impact factor: 3.647

Review 2.  Potential for Screening for Pancreatic Exocrine Insufficiency Using the Fecal Elastase-1 Test.

Authors:  J Enrique Domínguez-Muñoz; Philip D Hardt; Markus M Lerch; Matthias J Löhr
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

3.  Identification of risk factors for pancreatic exocrine insufficiency after pancreaticoduodenectomy using a 13C-labeled mixed triglyceride breath test.

Authors:  Seiko Hirono; Yoshiaki Murakami; Masaji Tani; Manabu Kawai; Ken-ichi Okada; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Naoya Nakagawa; Naru Kondo; Hiroki Yamaue
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

4.  Pancreatic exocrine insufficiency after pancreaticoduodenectomy is more prevalent with pancreaticogastrostomy than with pancreaticojejunostomy. A retrospective multicentre observational cohort study.

Authors:  Geert Roeyen; Miet Jansen; Laure Ruyssinck; Thiery Chapelle; Aude Vanlander; Bart Bracke; Vera Hartman; Dirk Ysebaert; Frederik Berrevoet
Journal:  HPB (Oxford)       Date:  2016-10-07       Impact factor: 3.647

Review 5.  Delayed Gastric Emptying and Gastric Remnant Function After Pancreaticoduodenectomy: A Systematic Review of Objective Assessment Modalities.

Authors:  Tim H-H Wang; Anthony Y Lin; Keno Mentor; Gregory O'Grady; Sanjay Pandanaboyana
Journal:  World J Surg       Date:  2022-10-23       Impact factor: 3.282

6.  Predictive factors for exocrine pancreatic insufficiency after pancreatoduodenectomy with pancreaticogastrostomy.

Authors:  Hiroyuki Nakamura; Yoshiaki Murakami; Kenichiro Uemura; Yasuo Hayashidani; Takeshi Sudo; Hiroki Ohge; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2009-05-05       Impact factor: 3.452

7.  Pylorus-resecting pancreaticoduodenectomy offers long-term outcomes similar to those of pylorus-preserving pancreaticoduodenectomy: results of a prospective study.

Authors:  Manabu Kawai; Masaji Tani; Seiko Hirono; Ken-Ichi Okada; Motoki Miyazawa; Hiroki Yamaue
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

8.  Enzyme replacement therapy for pancreatic insufficiency: present and future.

Authors:  Aaron Fieker; Jessica Philpott; Martine Armand
Journal:  Clin Exp Gastroenterol       Date:  2011-05-04

9.  Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes.

Authors:  Aoi Hayasaki; Yasuhiro Murata; Masanobu Usui; Taemi Hibi; Takehiro Fujii; Yusuke Iizawa; Hiroyuki Kato; Akihiro Tanemura; Yoshinori Azumi; Naohisa Kuriyama; Masashi Kishiwada; Shugo Mizuno; Hiroyuki Sakurai; Katsunori Uchida; Shuji Isaji
Journal:  Biomed Res Int       Date:  2019-04-04       Impact factor: 3.411

Review 10.  European guideline on indications, performance and clinical impact of 13 C-breath tests in adult and pediatric patients: An EAGEN, ESNM, and ESPGHAN consensus, supported by EPC.

Authors:  Jutta Keller; Heinz F Hammer; Paul R Afolabi; Marc Benninga; Osvaldo Borrelli; Enrique Dominguez-Munoz; Dan Dumitrascu; Oliver Goetze; Stephan L Haas; Bruno Hauser; Daniel Pohl; Silvia Salvatore; Marc Sonyi; Nikhil Thapar; Kristin Verbeke; Mark R Fox
Journal:  United European Gastroenterol J       Date:  2021-06-14       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.